DA
MNTA

Duality Advisers’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Duality Advisers’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,633
Closed -$553K – 668
2020
Q2 		$553K Buy
+16,633
New +$530K 0.05% 299
2020
Q1 		– Sell
-31,646
Closed -$624K – 357
2019
Q4 		$624K Buy
+31,646
New +$506K 0.04% 320

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Duality Advisers's MNTA Position: Q3 2020 in Review

Duality Advisers sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 16,633 shares — an estimated $553K sold.

Duality Advisers first reported a position in MNTA in Q4 2019 and held it in 2 quarters. The position peaked at $624K in Q4 2019. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Duality Advisers reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Duality Advisers sold 16,633 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $553K.
  • Duality Advisers first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2019 and held it in 2 quarters.
  • Duality Advisers's Momenta Pharmaceuticals, Inc. position peaked at $624K in Q4 2019.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Duality Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.